欢迎访问《解剖学报》官方网站!今天是 English
肿瘤生物学

多肽-N乙酰氨基半乳糖转移酶10在肺癌中的表达及意义

  • 蔡翠霞 ,
  • 高媛 ,
  • 刘玥 ,
  • 王涵多
展开
  • 南方医科大学基础医学院,广东省生物芯片重点实验室,广州 510515

收稿日期: 2019-01-03

  修回日期: 2019-04-08

  网络出版日期: 2020-04-06

Expression of polypeptide N-acetylgalactosaminyltransferase-10 in lung cancer#br#

  • CAI Cui-Xia ,
  • GAO Yuan ,
  • LIU Yue ,
  • WANG Han-Duo
Expand
  • School of Basic Medical Science, Guangdong Provincial Key Laboratory of Single Cell Technology and Application, Southern Medical University, Guangzhou 510515, China

Received date: 2019-01-03

  Revised date: 2019-04-08

  Online published: 2020-04-06

摘要

目的  探讨检测多肽-N乙酰氨基半乳糖转移酶10(pp GalNAc-T10)单细胞技术与应用蛋白在肺癌、乳腺癌和结肠癌中的表达。  方法  采用免疫组织化学检测ppGalNAc-T10在110例肺癌组织、100例乳腺癌组织和110例结肠癌组织中的表达;不同的肿瘤均有10例相对应的正常组织作为对照。  结果  同正常肺组织相比较,ppGalNAc-T10在肺癌组织中表达较低;且ppGalNAc-T10的表达与肿瘤侵袭深度相关(P<0.01)。PpGalNAc-T10蛋白在乳腺癌和结肠癌及其相对应的正常组织的表达差异无显著性。  结论  PpGalNAc-T10在肺癌中,有可能成为的1个有效标记蛋白。

本文引用格式

蔡翠霞 , 高媛 , 刘玥 , 王涵多 . 多肽-N乙酰氨基半乳糖转移酶10在肺癌中的表达及意义[J]. 解剖学报, 2020 , 51(2) : 206 -210 . DOI: 10.16098/j.issn.0529-1356.2020.02.009

Abstract

Objective The purpose of this study is to investigate the expression of the polypeptide N-acetylgalactosaminyltransferase-10(ppGalNAc-T10) protein in lung and breast and colon cancer.  Methods  Immunohistochemistry was used to analyse ppGalNAc-T10 expressions in 110 lung cancer tissues, 100 breast cancer tissues and 110 colon cancer tissues. Meanwhile, different cancer has 10 cases of normal tissues as control.   Results  The expression of ppGalNAc-T10 in normal lung tissue was higher compared with that in lung cancer organizations, and ppGalNAc-T10 positive expression was found to be significantly associated with invasion depth of tumor (P<0.01). PpGalNAc-T10 protein expression in breast and colon cancer was no significantly difference than that in non-tumor breast and colon tissue.   Conclusion  PpGalNAc-T10 expression is a useful marker in lung cancer.

参考文献

[1]  Ten Hagen KG, Fritz TA, Tabak LA, et al. All in the family: the UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferases[J]. Glycobiologyvol, 2003, 13(1): 1R-16R. 
[2] Huang MJ, Hu RH, Chou CH, et al. Knockdown of GALNT1 suppresses malignant phenotype of hepatocellular carcinoma by suppressing EGFR signaling[J]. Oncotarget, 2015, 6(8):5650-5665. 
[3] Guo JM, Chen HL, Wang GM, et al. Expression of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase-12 in gastric and colonic cancer cell lines and in human colorectal cancer[J]. Oncology, 2004, 67(34):271-276.
[4] Gu C, Oyama T, Osaki T, et al. Low expression of polypeptide GalNAc N-acetylgalactosaminyl transferase-3 in lung adenocarcinoma: impact on poor prognosis and early recurrence[J]. Br J Cancer, 2004, 90(2):436-442. 
[5] Wang ZQ, Bachvarova M, Morin C, et al. Role of the polypeptide N-acetylgalactosaminyltransferase 3 in ovarian cancer progression: possible implications in abnormal mucin O-glycosylation[J]. Oncotarget, 2014, 5(2):544-560. 
[6] Lina MC, Huang MJ, Liu CH, et al. GALNT2 enhances migration and invasion of oral squamous cell carcinoma by regulating EGFR glycosylation and activity[J]. Oral Oncology, 2014, 50(5):478-484.
[7] Gao Y, Liu Z, Feng J, et al. Expression pattern of polypeptide N-acetylgalactosaminyltransferase-10 in gastric carcinoma[J]. Oncol Lett, 2013, 5(1):113-116.
[8] Li Z, Yamada S, Wu Y, et al. Polypeptide N-acetylgalactosaminyltransferase-6 expression independently predicts poor overall survival in patients with lung adenocarcinoma after curative resection[J]. Oncotarget, 2016, 7(34): 54463-54473
[9] Berois N, Mazal D, Ubillos L, et al. UDP-N-Acetyl-D-Galactosamine: Polypeptide N-Acetylgalactosaminyltransferase-6 as a New Immunohistochemical Breast Cancer Marker[J]. J Histochem Cytochem, 2006, 54(3): 317-328.
[10] He H, Shen Z, Zhang H, et al. Clinical significance of polypeptide N-acetylgalactosaminyl transferase-5 (GalNAc-T5) expression in patients with gastric cancer[J]. Br J Cancer, 2014, 110(8): 2021-2029.
文章导航

/